Technical Analysis for AEMD - Aethlon Medical, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Fell Below 20 DMA | Bearish | -0.88% | |
Bollinger Band Squeeze | Range Contraction | -0.88% | |
Narrow Range Bar | Range Contraction | -0.88% | |
Inside Day | Range Contraction | -0.88% | |
50 DMA Resistance | Bearish | -3.83% | |
Crossed Above 20 DMA | Bullish | -3.83% | |
MACD Bullish Signal Line Cross | Bullish | -3.83% |
Alert | Time |
---|---|
20 DMA Resistance | about 19 hours ago |
10 DMA Resistance | about 19 hours ago |
Down 3% | about 19 hours ago |
Fell Below Previous Day's Low | about 19 hours ago |
Down 2 % | about 19 hours ago |
Get a Trading Sidekick!
- Earnings date: 11/12/2024
Aethlon Medical, Inc. Description
Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The company's Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. It is also developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The company was founded in 1991 and is based in San Diego, California.
Classification
Sector: Technology
Industry: Scientific & Technical Instruments
Keywords: Medicine Cancer Biology Infectious Diseases Treatment Of Cancer Neurological Disorders Coronavirus Hepatitis Viruses Immunodeficiency Urological Disorders Virus Antiviral Drug Exosome Sepsis Therapeutic Device Vesicles
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.3499 |
52 Week Low | 0.2375 |
Average Volume | 802,045 |
200-Day Moving Average | 0.91 |
50-Day Moving Average | 0.40 |
20-Day Moving Average | 0.39 |
10-Day Moving Average | 0.39 |
Average True Range | 0.03 |
RSI (14) | 46.52 |
ADX | 17.8 |
+DI | 19.96 |
-DI | 15.39 |
Chandelier Exit (Long, 3 ATRs) | 0.37 |
Chandelier Exit (Short, 3 ATRs) | 0.46 |
Upper Bollinger Bands | 0.42 |
Lower Bollinger Band | 0.36 |
Percent B (%b) | 0.4 |
BandWidth | 13.23 |
MACD Line | -0.01 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.0002 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.41 | ||||
Resistance 3 (R3) | 0.41 | 0.40 | 0.41 | ||
Resistance 2 (R2) | 0.40 | 0.39 | 0.40 | 0.41 | |
Resistance 1 (R1) | 0.39 | 0.39 | 0.39 | 0.39 | 0.41 |
Pivot Point | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
Support 1 (S1) | 0.37 | 0.38 | 0.37 | 0.37 | 0.36 |
Support 2 (S2) | 0.36 | 0.37 | 0.36 | 0.36 | |
Support 3 (S3) | 0.35 | 0.36 | 0.36 | ||
Support 4 (S4) | 0.36 |